ASCP Annual Meeting 2026

NeuroKaire at the ASCP Annual Meeting

NeuroKaire participated in the ASCP Annual Meeting in Miami, Florida, with a poster presentation held on May 27–28.

During the meeting, the NeuroKaire team presented data highlighting BrightKaire™, our precision psychiatry platform designed to help personalize antidepressant treatment through patient-derived neurons, artificial intelligence, and advanced biological insights.

The poster presentation shared findings supporting BrightKaire’s potential to help reduce the trial-and-error process in depression care by providing clinicians with data-driven insights into how individual patients may respond to different antidepressant medications.

Highlights:

• Poster presentation at the ASCP Annual Meeting
• Clinical data supporting BrightKaire™ and personalized antidepressant treatment
• Focus on reducing trial-and-error prescribing in depression care
• Engagement with psychiatrists, researchers, and clinical innovators
• Continued advancement of precision psychiatry through patient-derived neuron technology

NeuroKaire was proud to share its work with the ASCP community and contribute to the growing conversation around precision medicine in psychiatry.

Missed Us at ASCP?

If you weren’t able to attend, we’d still love to connect! Learn more about how NeuroKaire’s solutions can benefit your practice and improve patient outcomes.

Contact Us or Schedule a Meeting